Allergan Q3 Profit Beats Estimates - Quick Facts

(RTTNews) - Allergan, Inc. (AGN) reported that its third-quarter net earnings attributable to company increased to $312.5 million or $1.03 per share from $299.8 million or $1.00 per share, last year. Non-GAAP net earnings attributable to Allergan was $540.0 million or $1.78 per share, for the quarter.

On average, 16 analysts polled by Thomson Reuters expected the company to report profit per share of $1.68 for the quarter. Analysts' estimates typically exclude special items.

Revenues increased to $1.82 billion from $1.56 billion, a year ago. Analysts expected revenue of $1.78 billion for the quarter.

Allergan also announced that its Board has declared a third quarter dividend of $0.05 per share, payable on December 11, 2014 to stockholders of record on November 20, 2014.

For the full year of 2014, Allergan expects: total product net sales between $7.08 billion and $7.16 billion, excluding any future anticipated revenue from the transition services agreements related to the sale of the obesity intervention business. Non-GAAP earnings per share attributable to stockholders is expected to be between $6.27 and $6.30. Analysts expect the company to report fiscal 2014 profit per share of $6.12 on revenue of $7.15 billion.

For the fourth quarter of 2014, Allergan expects: total product net sales between $1.85 billion and $1.92 billion, excluding any future anticipated revenue from the transition services agreements related to the sale of the obesity intervention business. Non-GAAP earnings per share attributable to stockholders is expected to be between $1.80 and $1.83. Analysts expect the company to report fourth-quarter earnings per share of $1.74 on revenue of $1.87 billion.